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Abstract
Background: Ectromelia virus is a natural mouse pathogen, causing mousepox. The cytotoxic T (Tc) cell granule serine-
protease, granzyme B, is important for its control, but the underlying mechanism is unknown. Using ex vivo virus immune Tc
cells, we have previously shown that granzyme B is able to activate several independent pro-apoptotic pathways, including
those mediated by Bid/Bak/Bax and caspases-3/-7, in target cells pulsed with Tc cell determinants.
Methods and Findings: Here we analysed the physiological relevance of those pro-apoptotic pathways in ectromelia
infection, by incubating ectromelia-immune ex vivo Tc cells from granzyme A deficient (GzmB+ Tc cells) or granzyme A and
granzyme B deficient (GzmA6B2/2 Tc cell) mice with ectromelia-infected target cells. We found that gzmB-induced
apoptosis was totally blocked in ectromelia infected or peptide pulsed cells lacking caspases-3/-7. However ectromelia
inhibited only partially apoptosis in cells deficient for Bid/Bak/Bax and not at all when both pathways were operative
suggesting that the virus is able to interfere with apoptosis induced by gzmB in case not all pathways are activated.
Importantly, inhibition of viral replication in vitro, as seen with wild type cells, was not affected by the lack of Bid/Bak/Bax
but was significantly reduced in caspase-3/-7-deficient cells. Both caspase dependent processes were strictly dependent on
gzmB, since Tc cells, lacking both gzms, neither induced apoptosis nor reduced viral titers.
Significance: Out findings present the first evidence on the biological importance of the independent gzmB-inducible pro-
apoptotic pathways in a physiological relevant virus infection model.
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Introduction
Cytotoxic T (Tc) lymphocytes and natural killer (NK) cells are
key components of the host immune system protecting against
tumor development and intracellular pathogens, in particular
viruses. In vitro, they kill virus-infected or transformed cells by a
mechanism known as ‘programmed cell death’, apoptosis [1,2]. Tc
cells employ two major mechanisms to induce apoptosis of target
cells: one is via the engagement of a death receptor on the cell
surface of target cells by a specific ligand (death ligand) expressed
by Tc cells (i.e. CD95 (Fas)/CD95L (FasL)) [3,4] and the other is
the granule exocytosis pathway [4,5].
The granule exocytosis pathway consists of the intracellular
mobilization and release of the content of specialized organelles
(cytotoxic granules) via the immunological synapse [6]. The
principal granule components with cytotoxic potential are the
pore forming protein perforin (perf) [7] and a family of serine-
proteases named granzymes (gzm), of which gzmA [8,9] and
gzmB [10,11] are the most abundant and best characterized.
The availability of mice deficient in one or more of these
cytolytic effector molecules has provided evidence of their role in
controlling virus infections [12–17] and protection from
tumours [18–22]. This control is facilitated by the induction of
apoptosis via one of two major pathways, either the extrinsic
(activated by death receptor engagement) or the intrinsic or
mitochondrial-mediated (activated by cellular stress) apoptotic
pathway. At least three main interconnected cellular compo-
nents have been shown to be responsible for activation and/or
regulation of those pathways: the caspases [23], the transcription
factor p53 [24] and the Bcl-2 family, consisting of pro-apoptotic
(Bid, Bak, Bax, Bim, etc.) and anti-apoptotic (Bcl-2, Bcl-XL, Mcl-
1, etc.) proteins [25].
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Viruses have been shown to interfere with the above-mentioned
apoptotic mechanisms in order to optimize their replication in the
host cell [26–28]. Ortho-poxviruses encode a number of apoptosis
inhibitors. Members of this family, vaccinia virus (VACV), cowpox
(CPXV) and rabbit pox (RPXV) are able to block the extrinsic,
death receptor-mediated, as well as the intrinsic pathways.
Extrinsic and mitochondrial apoptotic processes are inhibited
through either the viral CrmA-like caspase-8/-10 inhibitor SPI-2
[29–31], and/or the Bak and BH3-only inhibitor F1L [32–34] or
the Bcl-2 homologue N1L [35], respectively. Ectromelia virus
(ECTV) is the causative agent of mousepox and also an
orthopoxvirus [36]. Unlike VACV, CPXV and RPXV, ECTV
is a natural pathogen of mice. ECTV infection of mice is therefore
uniquely able to provide physiologically relevant insights into co-
evolved host-pathogen relationships. Like other orthopoxviruses,
ECTV is able to inhibit death receptor-induced apoptosis by SPI-2
expression [37–39] and UV-induced apoptosis by the ring finger
protein p28 in vitro [40]. In addition, N1L and F1L orthologues
are found in the ECTV genome [41].
Perf, gzmA and gzmB are all important for in vivo ECTV
control, [13,14]. GzmA and/or gzmB are crucial for perf-
mediated induction of apoptosis by ex-vivo virus-immune Tc cells
[42–45], albeit not for cellular lysis, as observed by 51Cr release
[42,45]. These results, together with the inability of ECTV to
inhibit cellular lysis induced by perf/gzms [37], suggest that
apoptotic cell death induction by gzmA and/or gzmB may be
crucial for the recovery of mice from ECTV infection.
GzmB of virus-immune ex vivo Tc cells activates several distinct
pro-apoptotic pathways including those mediated by caspases and
the Bcl-2 family [43,44]. Since gzmB is important in the control of
ECTV infection and ECTV is able to inhibit a number of
apoptotic pathways, we speculated that the pleiotropic effect of
mouse gzmB has evolved to counteract virus evasion strategies of
apoptosis. We tested this hypothesis, by using ex vivo ECTV-
immune Tc cells to analyse the effect of ECTV infection during
apoptosis induced by perf/gzmB. Our results indicate that ECTV
is not able to inhibit apoptosis induced by ex vivo Tc cells, which is
critically dependent on gzmB expression. In addition, this process
correlates with reduced ECTV replication in infected target cells.
Further analysis of those processes in target cells deficient in the
mitochondrial or caspase apoptotic pathways reveal the relative
importance of these pathways to induce apoptosis in ECTV
infected cells and to inhibit ECTV replication.
Results
Infection of MEF cells by ECTV
To analyze the putative inhibitory effect of ECTV on apoptosis
induced by gzmB we used ECTV-immune ex vivo-derived Tc cells
from gzmA2/2 mice (gzmB+ Tc cells) as effector cells, and three
mouse embryonic fibroblast (MEF) lines, wild type (wt), and two
lines derived from mutant mice deficient in either the proapototic
molecules Bak and Bax (MEF.BakxBax2/2) or the caspases 3 and
7 (MEF.Casp3x72/2) as target cells. All cell lines have previously
been shown to be susceptible to gzmB+ Tc-induced cell death [44].
We initially characterized permissibility of MEFs to infection with
virulent ECTV Moscow (Mo) strain and attenuated ECTV
Hampstead Egg (HE) strain. Both virus strains replicated with similar
efficiency in all cell lines, as evidenced by viral plaque assays (data not
shown). In addition, intracellular FACS staining of virus with anti-
ECTV rabbit serum indicated that at 4 or 24 h after virus infection,
similar percentages of cells became antibody positive with either Mo-
or HE-ECTV strains (Fig. S1A). Furthermore, we found that mRNA
of the EVM025 protein (the ECTV orthologue of the VACV F1L
protein, a specific inhibitor of Bak, a proapoptotic member of the Bcl-
2 family [32–34]) was already expressed after 4 h in Mo- or HE-
ECTV infected (MOI 3:1 (3 pfu/cell)) but not mock treated cells and
also contained the BH3-like domain responsible for Bak inhibition
(Fig. S1B). In addition, as reported for VV [32–34], Mo- and HE-
ECTV inhibited apoptosis induced by the bacterial metabolite
staurosporin, most probably via VACV F1L (STP. Fig. S1C). At 4–
8 h after infection, cells are still viable and cell death markers are not
yet detectable (Fig S1D). These data indicate that MEFs are
efficiently infected by Mo- and HE-ECTV. In addition, they show
that Mo/HE-ECTV express putative apoptosis inhibitors in infected
targets early in the virus replication phase, before the infected cells die
as a consequence of viral cytopathic effects (.24 h post infection).
In vivo generation of ECTV-immune Tc cells
To generate Tc cells immune to ECTV, we infected wt or
gzmA6B cluster2/2 mice (which are deficient in gzmA and gzmB,
but also display a reduced expression of several gzmB-downstream
gzm [46]) with 105 PFU HE-ECTV intravenously (iv). We used
the attenuated HE-ECTV, because Mo-ECTV causes severe liver
and spleen destruction in gzmA6B2/2 mice, rendering an
analysis of splenocytes not feasible [14]. At 6 d post-infection
splenic CD8+ cells were enriched and found to express gzmA,
gzmB and gzmK mRNA but not gzmC in wt animals (Fig. S2A).
As expected [44], gzmB+ Tc cells expressed only gzmB and gzmK,
and gzmA6B2/2 Tc cells only gzmK. Primary in vitro alloreactive
B6 wt Tc cells expressed also gzmC. Proteins for gzmA and gzmB
were similarly expressed in wt Tc cells, whereas, as expected, only
gzmB was produced in gzmB+ Tc cells and neither of them in
gzmA6B2/2 Tc cells (Fig. S2B). CFSE labelled, ex vivo Tc cells
were tested for their cytolytic potential against mock-treated,
ECTV-infected or peptide-pulsed MEFs and CFSE negative cells
(target cells) were analysed for induction of the following
proapoptotic features: PS translocation using Annexin V staining
and membrane integrity by 7-amino actinomycin D staining (i.e.
annexinV+/AAD2 equates with early apoptosis, AnnexinV+/
AAD+ is indicative of secondary necrosis). We found that B6 and
gzmA2/2 ex vivo Tc cells specifically induced apoptosis in ECTV-
infected and peptide-pulsed MEFs (Fig. S2C). In contrast,
gzmA6B2/2 derived Tc cells did not induce specific apoptosis
(Fig. S2C). This indicates that ECTV-immune ex vivo Tc cells
require gzmB to efficiently induce cell death markers (apoptosis:
annexin V or necrosis: AAD)) in MEFs. Similar conclusions have
been reached previously using peptide-pulsed targets in the
LCMV mouse model [43,44].
Results obtained with different target cells, MC57G or EL4.F15
cells, confirmed the results obtained with MEFs (Fig. 1 vs Fig.
S2C): Only gzmB+ Tc cells, but not gzmA6B2/2 derived ECTV-
immune ex vivo Tc cells could induce significant apoptosis on
peptide-pulsed or ECTV-infected target cells. These results are
consistent with the high susceptibility of gzmA6B2/2 mice to
ECTV infection and suggest that pro-apoptotic processes induced
by perf and gzms may be responsible for the gzm-dependent
recovery from ECTV infection. In addition, they show that lack of
gzmA does not affect the pro-apoptotic potential of ECTV-
immune ex vivo Tc cells in vitro. For these reasons, we used ECTV-
immune ex vivo Tc cells from gzmA2/2 mice (gzmB+ Tc cells) as
effector cells in all further experiments.
ECTV does not inhibit PS translocation induced by ex vivo
immune gzmB+Tc cells
As we wanted to see whether ECTV virulence correlated with
inhibition of gzmB-induced apoptosis, we compared apoptosis
induction by ex vivo gzmB+ Tc cells on MEFs infected with either
Granzyme B and Mousepox
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Figure 1. Apoptosis induced by ex vivo ECTV-immune Tc cells on target cells. CFSE labelled ect ex vivo Tc cells (C, B6, gzmA2/2 or
gzmA6B2/2; D, gzmA2/2 or gzmA6B2/2) were incubated with mock-treated, peptide-pulsed or Mo-ECTV-infected (5 h, MOI = 3) MEF.wt, EL4 and
MC57G cells for 3 h. Early (AV+/AAD2, filled bars) and late apoptotic/necrotic (AV+/AAD+, empty bars) cells in the CFSE2 negative cell population
(target cells) were analysed by FACS. Data are given as mean+/2SEM of 2 independent experiments.
doi:10.1371/journal.pone.0007512.g001
Granzyme B and Mousepox
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the virulent Mo-ECTV or the attenuated HE- strain. As controls
we used peptide-pulsed or mock-treated MEFs. We first
determined whether Mo- and HE-ECTV, render target cells
similar recognizable to ECTV-immune ex vivo Tc cells. We
analysed Tc cell degranulation (by measuring the number of Tc
cells expressing the lysosomal marker, CD107a (Lamp1), on their
cell membrane, [44]) after incubation with ECTV-infected,
peptide-pulsed or mock treated MEFs (Fig 2A). No significant
differences in the proportion of CD107a+ Tc cells after incubation
with MEF infected with either strain of ECTV was found. Thus, ex
vivo ECTV-immune Tc cells recognise MEF with similar efficiency
after infection with either virulent or attenuated ECTV, and
degranulation correlated with apoptosis induced by gzmB+ Tc
cells on MEFs (Fig 2B). GzmB+ Tc cells induced apoptosis to the
Figure 2. Degranulation of ex vivo gzmB+ Tc cell and PS translocation on target cells.MEF.wt cells were mocked-treated, peptide-pulsed or
infected (5 h) with Mo- or HE-ECTV. A, MEF-wt target cells were incubated for 5 h with ex vivo Tc cells in the presence of monensin and anti-CD107a
(FITC), followed by FACS staining with anti-CD8 (APC) and anti-CD107a (FITC). Representative dot plots (with % of cells in top right and bottom right
quadrants) and means+/2SEM of percent CD107a+ CD8+ cells are shown from 5 independent experiments performed by duplicate. B, MEF-wt target
cells were incubated with CFSE labelled ex vivo Tc cells for 3 h and PS translocation (annexin V-PE staining) and membrane integrity (AAD staining)
were analysed by FACS in the CFSE2 negative cell population (target cells). Data are given as mean+/2SEM of 10 independent experiments.
doi:10.1371/journal.pone.0007512.g002
Granzyme B and Mousepox
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same extend on peptide-pulsed and Mo- or HE-ECTV infected
MEFs (4–5 h post-infection) compared to mock-treated targets
(Fig. 2B). Together with the previous findings that apoptosis
(measured by PS translocation) was neither affected by virulent
Mo-ECTV in two other cell lines tested, EL4 and MC57G (Fig. 1),
the data suggest that cell death in these target cells is not altered by
the virus.
Together, these findings indicate that gzmB of ex vivo ECTV-
immune Tc cells is able to overcome the anti-apoptotic potential of
ECTV that is evident against staurosporine.
ECTV does not inhibit other apoptotic markers induced
by ex vivo gzmB+ Tc cells
Although gzmB+ Tc cell-mediated PS translocation was not
inhibited in MEFs infected with ECTV viruses, we investigated
whether other pro-apoptotic features, elicited by gzmB, may be
affected. ECTV-immune ex vivo gzmB+ Tc cells were incubated
with MEFs either mock, peptide-pulsed or Mo- or HE-ECTV-
infected and monitored for a) loss of mitochondrial membrane
potential by staining with DiOC6(3), (Fig. 3A), b) caspase 3
activation by staining with anti-active caspase-3 antibody, (Fig. 3B)
and c) conformational changes of Bak and Bax by staining with
mAbs that recognise N-terminal epitopes of Bak and Bax,
respectively, which are exposed only upon their functional
activation (Fig. 3C). None of the parameters tested were
significantly affected as a result of ECTV infection (Fig. S1D),
although an increased caspase 3 activation in ECTV infected
target cells was observed (Fig. 3B), which possibly reflected early
caspase 3 induction by ECTV itself [47].
Ex vivo ECTV-immune gzmB+ Tc cells induce calreticulin
translocation, independently of ECTV infection
It was possible that ECTV affects the quality of cell death
thereby evading specific immunity in order to hide of the immune
system. It is well established that, under certain conditions, dying
cells express particular signals relevant for the induction of
immune responses, including immunological memory formation.
One of these signals is calreticulin, which may be exposed on
membranes of dying cells [48,49]. We tested calreticulin exposure
on the outer cell membrane of Tc cell-treated, ECTV-infected
target cells. Ex vivo gzmB+ Tc cells were incubated with MEFs
(mock, peptide-pulsed or Mo- or HE-ECTV-infected) and
calreticulin exposure was analysed by FACS (Fig. 3D). There
was no difference in calreticulin membrane expression induced
irrespective whether MEFs were peptide-pulsed or infected with
ECTV.
ECTV inhibits apoptosis induced by ex vivo ECTV-
immune gzmB+ Tc cells in target cells lacking Bak and
Bax
CPXV SPI-2 (CrmA) [50], but not ECTV SPI-2 [39] was
shown to inhibit gzmB in a cell free system or after transient
induced expression in a cell line, respectively. Our data indicate
that ECTV encoded inhibitors are not able to generally block
gzmB+Tc cell-mediated apoptosis in wt-MEFs. Thus the question
arises; if gzmB’s broadly induced apoptosis can only be mediated
by one of the two major pathways in virus infected target cells. We
therefore used MEF.BakxBax2/2 and MEF.Casp3x72/2 (mock-
treated, peptide-pulsed or Mo-ECTV-infected) target cells with ex
vivo ECTV-immune gzmB+ Tc cells and analysed the induction of
pro-apoptotic features (Fig. 4). In agreement with the LCMV
model [44], we found that PS translocation induced by ECTV-
immune ex vivo gzmB+CTLs on both MEF.wt targets, peptide-
pulsed and Mo-ECTV-infected, was completely dependent on
caspases-3 and/or -7.
This was paralleled in the ECTV system for peptide-pulsed
MEF.BakxBax2/2, which were as susceptible to gzmB+ Tc cell-
induced PS exposure as peptide-pulsed MEF.wt. In contrast Mo-
ECTV-infected MEF.BakxBax2/2 were around 50% less suscep-
tible than Mo-ECTV-infected MEF.wt. This suggests that, in the
absence of Bak and/or Bax, ECTV interferes with gzmB+ Tc cell-
disrupted plasma membrane asymmetry.
Since gzmB-facilitated PS translocation is critically dependent
on casp3x7 [44], but amplified via mitochondrial processes,
including apoptosome/caspase-9 complex formation, this finding
provides evidence that the mitochondrial pathway is critical for
efficient gzmB-induced apoptosis of ECTV-infected cells.
GzmB+ but not gzmA6B2/2 Tc cells inhibit ECTV
replication in vitro by a caspase dependent mechanism
To address the question, whether differential inhibition of
gzmB-induced apoptosis by ECTV affects virus replication, we
infected MEF target cells with Mo-ECTV for 3 or 18 h before
subjecting them to attack by ex vivo wt B6, gzmB+ or gzmA+
(gzmB2/2) Tc cells. Viral titers in cultures were analysed after 4
or 44 h of co-incubation. In those targets that had been infected
for 18 h before exposure to virus-immune Tc cells, high titers
were observed already at the beginning of the co-cultures
(Fig. 5A). These titers did not change over the subsequent 44 h,
independent on the presence or absence of virus-immune Tc
cells. This suggests that virus had completed a replication cycle
before exposure to virus-immune Tc cells, and that virtually all
susceptible target cells had been infected and maximally
replicated virus. However, early (3 h) after target infection, low
titers were observed, consistent with the eclipse phase of virus
infection (Fig 5A). Spleens of the HE-ECTV infected mice that
provided the virus-immune Tc cells had no detectable virus at
the time of sacrifice (not shown), ruling out a contamination from
this source. WT Tc cells were then able to completely suppress
any viral replication in these targets, since viral titers in their
cultures did not increase over the next 44 h, whereas in the
absence of Tc cells, detectable virus increased 100-fold during
this time (Fig 5A). In contrast, exposure to gzmA+ (gzmB2/2)
and gzmB+ (gzmA2/2) virus-immune Tc cells resulted in a
graded suppression of viral replication.
Next, we tested the ability of gzmA+, gzmB+ or gzmA6B2/2 Tc
cells to suppress viral titers in targets infected shortly before Tc cell
attack (Fig 5B). We found an increasing ability of Tc cells to
suppress ECTV replication, depending on whether they expressed
gzmA, gzmB or both. This viral suppression activity in vitro
correlated with apoptosis induced by those Tc cells (Fig. 1 and Fig.
S2C) and indicated that gzmB’s ability to overcome ECTV
inhibition of apoptosis likely has direct effects on virus replication
and/or clearance. Furthermore, gzmA also clearly showed an
antiviral effect in these assays, despite not contributing to any of
the analyzed apoptosis parameters (Fig. S2C). Finally, we tested
whether the increased resistance of ECTV-infected MEF.Bakx-
Bax2/2 and MEF.Casp3x72/2 cells to apoptosis induced by
gzmB+ Tc cells yielded a higher ECTV replication rate in those
cells. As shown in the experiment in Fig 5C we found that upon
incubation with gzmB+ Tc cells, ECTV replication was around
106 higher in MEF.Casp3x72/2 compared to both, MEF.wt or
BakxBax2/2 cells. An independent experiment yielded similar
results with a 100-fold difference between wt and casp3x72/2 cells
(not shown). This indicated that partial inhibition of gzmB+Tc cell
mediated apoptosis by ECTV in Bak and Bax-deficient target cells
does not interfere with suppression of virus replication in host cells.
Granzyme B and Mousepox
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In addition, the data show for the first time that casp3x7 are not
only important during Tc-mediated and gzmB-facilitated apopto-
sis, but critically involved in the control of ECTV replication in
vitro and indicate the biological relevance for the caspase
dependent apoptotic pathway in gzmB-mediated control of
ECTV.
Figure 3. Ex vivo gzmB+ Tc cell-induced mitochondrial damage, caspase 3 activation, Bak/Bax conformational change and
calreticulin translocation in ECTV-infected targets. Mock-treated, peptide-pulsed or Mo-ECTV-infected MEF.wt cells were incubated with CFSE
labelled (C) or unlabelled (A, B) ex vivo Tc cells for 3 h and mitochondrial membrane potential (DiOC6(3), A) caspase 3 activation (anti-active caspase
3-FITC antibody, B) were analysed in the CD82 population by FACS or Bak and Bax conformational change (anti-N-terminal Bak/Bax antibodies, C) and
calreticulin translocation (D) in the CFSE2 cell population. Data are given as mean+/2SEM of percent positive cells from 4 (A), 3 (B), 2 (C) or 4 (D)
independent experiments.
doi:10.1371/journal.pone.0007512.g003
Granzyme B and Mousepox
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Discussion
Tc cells [51], and gzmA/B [52] are essential for the recovery of
mice from primary infection by ECTV, mousepox, and it has been
assumed that the two gzms mediate their protective effect via
apoptosis induction of infected cells through the granule exocytosis
pathway. It has previously been shown that ECTV resistant B6
mice become 10 times more susceptible when gzmA is absent and
107 times more susceptible when both gzmA and B are lacking, as
demonstrated in the gzmA6B2/2 cluster knock-out mice [14].
Most probable, the latter finding is due to the inability of
gzmA6B2/2 Tc cells to induce pro-apoptotic processes, such as
PS translocation or membrane permeabilization in target cells, as
demonstrated here with three different types of target cells (EL4
lymphoma, embryonic fibroblasts and MC57G fibrosarcoma).
This contrasts with Tc cells from gzmA2/2 mice (gzmB+ Tc cells),
which exhibit no defect in their ability to induce apoptosis in
ECTV-infected targets. These results are in agreement with
previous findings in the LCMV-system [42–45]. Moreover, it
would be expected that if ECTV was able to efficiently block
gzmB-dependent in vivo processes, including apoptosis, gzmA2/2
mice should be as susceptible to ECTV infection as gzmA6B2/2,
which is not the case [14,53]. This is also in agreement with
reports showing that gzmB is not inhibited by ECTV encoded
serpins (including SPI-2/CrmA) [38,39]. Supporting these argu-
ments are the data presented here that apoptosis induced by
gzmB+ Tc cells is not abolished by ECTV infection. Although,
gzmC and gzmF are down regulated in the gzmA6B2/2 cluster
KO mouse, the participation of those gzms in ECTV resistance is
unlikely because they are not expressed at detectable levels in
ECTV-immune Tc cells from B6wt and gzmA2/2 mice.
The importance of gzmA and gzmB for ECTV control is
further supported by our present finding that ex vivo ECTV-
immune Tc cells from gzmA6B2/2 mice are unable to inhibit
ECTV replication in vitro in infected target cells in spite of the
presence of functional perforin present in those effectors. In
contrast Tc cells from wt or gzmA2/2 (expressing gzmB) mice
reduced ECTV titres more than 100-fold, which correlated with
their ability to induce apoptosis in those infected target cells. This
was expected since the virus needs a host cell to replicate and
ensure that viral progeny is disseminated to infect other cells.
However, the timing of the Tc cell encounter with the infected cell
appears to be critical. At late stages of infection, apoptosis
induction of infected cells appears to have no beneficial effect
because viral progeny formation is already complete, and lysis may
in fact facilitate the liberation of viral particles. Consistent with this
idea, we found that wt or gzmB+Tc cells are not able to reduce
viral titers if virus infection had progressed for 18 h (in contrast to
infection for 3 h) prior to Tc cell addition. Interestingly, gzmA also
showed an inhibitory effect on viral replication in vitro, consistent
with its demonstrable role in resistance of mice from mousepox.
The fact that we did not detect any contribution of gzmA to target
cell apoptosis means that either it mediates apoptosis by pathways
we did not analyze, or, more likely, given its lack of cytotoxicity
Figure 4. Ex vivo gzmB+ Tc cell-induced PS translocation in target cells lacking casp 3 and casp 7 or Bak and Bax. Mock-treated,
peptide-pulsed, or Mo- or HE-ECTV-infected MEF.wt, Casp3x72/2 or BakxBax2/2 cells were incubated with CFSE labelled ex vivo Tc cells for 3 h.
Percent early (AV+/AAD2, filled bars) and late apoptotic/necrotic (AV+/AAD+, empty bars) cells in the CFSE2 negative cell population (target cells) are
given as mean+/2SEM of 4 independent experiments.
doi:10.1371/journal.pone.0007512.g004
Granzyme B and Mousepox
PLoS ONE | www.plosone.org 7 October 2009 | Volume 4 | Issue 10 | e7512
under some circumstances [55], that its antiviral function is
mediated by pathways other than apoptosis induction.
It is known that immune-mediated apoptosis induction, as the
major threat to ECTV replication success, is mediated via several
proapoptotic pathways [43,44]. It is therefore likely that the full
range of cell death pathways induced by gzmB has evolved due to
selective pressure from pathogens like ECTV via its strategy to
inhibit selective apoptosis pathways. In this respect, one could
speculate that, in the course of its future co-evolution, ECTV may
acquire more diverse apoptosis inhibiting capabilities. However,
unimpaired virus replication may not necessarily constitute a
successful viral strategy as an early demise of the host would curtail
wide virus dissemination. On the other hand, it is possible that
ECTV at least partially inhibits gzmB-mediated apoptosis induc-
tion. The comparison of peptide-pulsed target cells, which are
labelled at 100% but targeted only by a minority of anti-ECTV Tc
cells on the one hand, and virus-infected target cells, which are only
infected at about 80% but display Tc cell determinants for the whole
spectrum of anti-ECTV Tc cells on the other hand, would make it
difficult to detect such a partial inhibition.
We also did not find any viral interference with calreticulin
membrane translocation after Tc cell attack. This is important
since it is now evident that dying cells signal the immune system to
get activated against antigens contained in those cells and one of
most critical is the calreticulin translocation. This indicates that
ECTV does not affect its immunogenicity, i.e. proper phagocytosis
of infected target cells and subsequent promotion of anti-viral/
protective Tc responses [48,49].
Using MEF.BakxBax2/2 cells and LCMV-immune ex vivo
gzmB+Tc cells, we have previously shown that Bak and Bax were
dispensable for PS translocation and caspase 3 activation induced
by gzmB [44]. However, Bak and Bax were required for gzmB+Tc
cell-induced cytochrome c release from mitochondria, a process
that may contribute to caspase-3 activation via an amplification
loop, including the apoptosome/caspase-9 complex [56]. We
tested if ECTV infection of target cells interferes with the processes
established in the LCMV system by using ECTV-immune ex vivo
gzmB+ Tc cells on ECTV –infected MEF.BakxBax2/2 or
MEF.Casp3x72/2 targets. Although ECTV did not affect
apoptosis induction by gzmB+Tc cells on MEF.wt, it partially
inhibited apoptosis in MEF.BakxBax2/2 cells. These data
highlight the importance of the mitochondrial apoptotic pathway,
triggered by gzmB, for efficient elimination of ECTV-infected
cells. However ECTV replication was inhibited as much in
Figure 5. Ex vivo Tc cells need gzmB to inhibit ECTV replication in vitro by a casp3x7 dependent process. A, B, MEF.wt cells were
infected for 3 or 18 h before being subjected to attack by ex vivo Tc cells from ECTV-immune WT (empty bars), gzmA2/2 (light bars), gzmB2/2
(dark bars) or gzmA6B2/2 (filled bars) mice for 4 (A, left panel) or 44 h (A, right panel, B). Cell suspensions were removed and analysed for viral titers
by plaque assay. C, MEF.wt, Casp3x72/2 or BakxBax2/2 cells were infected for 3 h before being subjected to attack by ex vivo Tc cells from ECTV-
immune gzmA2/2 mice for 44 h. Cell suspensions were removed and analysed for viral titers by plaque assay. Data in A and B are from separate
experiments. Data are given as mean+/2SD from two to four replicate cultures. Similar results were obtained in a separate experiment. ** statistically
significant (n = 3–4, P = 0,007); ns, no statistically significant (n = 3–4, P.0,05). Analysed by a two-tailed unrestricted t-student test comparing casp3x7
or BakxBax with wt.
doi:10.1371/journal.pone.0007512.g005
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MEF.BakxBax2/2 cells as in wt cells, but not at all when casp3x7
were absent. This result indicates that casp3x7 are not only
critically involved in apoptosis induced by mouse gzmB, but also in
the control of ECTV replication in vitro. This finding emphasizes
the importance of effectors caspases during apoptosis induced by
gzmB and at the same time it suggests that mitochondrial
amplification of gzmB-induced apoptosis is not needed to inhibit
ECTV replication.
The complexity of cell death induction by antiviral Tc cells in
virus-infected cells may thus reflect the evolutionary balance
achieved between pathogen and host, in which the former needs to
replicate sufficiently to ensure further spread, yet not enough to kill
its host prematurely.
In conclusion, the pleiotropic nature of cell death induced by
gzmB appears to be crucial to overcome the ability of ECTV to
interfere with apoptosis induced by Tc cells. Since ECTV is a
natural mouse pathogen and gzmB appears to be important for its
in vivo control, an understanding of their interplays is of great
importance in understanding host/parasite relationships.
Materials and Methods
Ethics statement
All experiments involving animals were performed in accor-
dance with Australian National University (ANU) Animal
Experimentations Ethics Committee.
Mouse strains and viruses
Inbred C57BL/6 (B6), and mouse strains deficient for gzmA
(gzmA2/2), and gzmA6B (gzmA6B2/2), bred on the B6
background were maintained at the John Curtin School of
Medical Research, Canberra and analysed for their genotypes as
described [18]. Male mice of 8 to 10 weeks of age were used in all
experiments and were performed in accordance with the local
animal ethics authority.
The mouse orthopoxvirus ectromelia strains Moscow (Mo-
ECTV) andHampstead Egg (HE-ECTV) have been described [37].
Generation of ex-vivo CD8+ cells
Mice were infected with 105 pfu HE-ECTV i.v. according to
established protocols [14]. On d6 post infection (p.i.), CD8+ cells
were positively selected from spleen using a-CD8-MicroBeads
(Miltenyi Biotec, Bergisch Gladbach, Germany) with an auto-
MACS (Miltenyi Biotec) and resuspended in MEM/5% FCS prior
to use in cytotoxic assays. Purity of selected CD8+ cells was
assessed by FACS staining and found to be between 95–98%.
Cell lines, cell culture and reagents
SV40 transformed mouse embryonic fibroblasts (MEFs) were
cultured in MEM supplemented with 10% FCS and 2-mercap-
toethanol (1025 M) at 37uC, 7% CO2. BaxxBak
2/2 MEFs were
generated as described previously [57] and were generously
provided by the S.J. Korsmeyer laboratory. Caspase 3x72/2
MEFs were generated as described previously and generously
provided by Richard A. Flavell [58]. The genotype of the various
MEF cells was periodically tested by genomic PCR and western
blot analysis. The mouse cell lines EL4.F15 and MC57G have
been previously described [42]. In some cases the general caspase
inhibitor Ac-ZVAD-fmk (Bachem; 100 mM) was added to cell
cultures as described [44].
Cell peptide pulsing and in vitro virus infection
Wt, Casp3x72/2, BakxBax2/2 MEFs, EL4 or MC57G cells
were incubated with 1025 M of the ectromelia immunodominant
Kb restricted peptide TSYKFESV-OH [59] for 2 h at 37uC.
Subsequently, cells were washed and used for the corresponding
assays.
Wt, Casp3x72/2, BakxBax2/2 MEFs, EL4 or MC57G cells
were infected with Mo or HE-ECTV at a multiplicity of infection
of 3 pfu per cell (MOI 3:1) for 4–5 h at 35uC. Subsequently, cells
were washed and used for the corresponding assays.
RT-PCR
Total RNA was extracted from up to 56106 cells, using the
QIAshredder spin columns, the RNeasy Mini Kit and the RNase-
free DNase Kit (all from Qiagen, Hilden, Germany) according to
manufacturer’s instructions and converted to cDNA as described
[60]. Specific transcripts were amplified by using specific primers.
The sense/antisense primers for gzmA, gzmB, gzmC, gzmK and
GADPH and the PCR conditions have been previously described
[44].
EVM025 (F1L) sequencing
Total RNA was isolated from MEF.wt cells previously infected
with Mo or HE-ECTV (MOI 3:1, 4 h, 35uC) using the
QIAshredder spin columns, the RNeasy Mini Kit and the
RNase-free DNase Kit (all from Qiagen, Hilden, Germany)
according to manufacturer’s instructions and converted to cDNA
as described [60]. Full EVM025 cDNA was amplified by using the
primers: 59-ACGGGATCCATGGACAATAGTATTTTGTCG-
3 (forward) and 59-TCGGGATCCTCATATCATGTATTTGA-
GAGTC-3 (reverse). PCR was done as follows: 95uC/4 min. (16);
95uC/30 sec., 51uC/1 min., 72uC/2 min. (56); 95uC/30 sec.,
58uC/1 min., 72uC/2 min. (356); 72uC/7 min. PCR products
were separated in agarose gel electrophoresis and fragments were
purified and sequenced by using the BigDye Terminator v3.1
Cycle Sequencing Kit and a capillary-based Applied Biosystems
3730 DNA Analyzer at the John Curtin School of Medical
Research’s DNA sequencing facility.
Flow cytometry
Cell populations were analysed for cell surface marker
expression and/or intracellular expression of gzmA and gzmB
by FACS as described [44]. Rabbit immune serum (IS) specific for
mouse gzmA (amgzmA) and mouse gzmB (a-mgzmB) has been
described [61].
Lamp-1 mobilization assay
Lamp-1 (CD107a) expression in the cell membrane of ex vivo Tc
cells was analysed as described [44]. Mock-treated, Peptide-pulsed
or ECTV infected MEF cells were incubated with ex vivo-derived
ECTV-immune Tc cells at 2:1 effector:target cell ratio (triplicates,
46104 targets and 86104 Tc cells/well). Subsequently, the mixed
cell population was treated with 1 ml (final dilution 1:200) of a-
Lamp-1-FITC antibody (BD) in the presence of monensin for 6 h
at 37uC, 7% CO2. Non-attached cells were collected, labelled with
a-CD8-APC antibody and analysed by FACS.
Analysis of pro-apoptotic processes
To analyse cell death induced by ex vivo Tc cells in target cells,
mock-treated, peptide-pulsed or ECTV-infected cells were incu-
bated with ex vivo-derived ECTV-immune Tc cells at 10:1
effector:target cell ratio for 3 h at 37uC, 7%CO2 [43]. In some
cases, Tc cells were previously labelled with CFSE 1 mM.
Subsequently, different apoptotic parameters were tested in the
target population (CD82 or CFSE2) by FACS with a FACScan
(BD) and CellQuestH software as follows:
Granzyme B and Mousepox
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a Cell membrane and mitochondrial membrane
perturbations
PS exposure and 7-amino-actinomycin D (7-AAD) uptake was
analysed by FACS using annexin V-PE and 7-AAD from BD
Pharmingen according to manufacturer’s indications. The mito-
chondrial membrane potential was measured with the fluorescent
probe 3,39-dihexyloxacarbocyanine iodide (DiOC6(3), Molecular
Probes) [44].
b Caspase-3 activation
Caspase 3 activation was analysed by FACS as described [44].
Cells were fixed with 4% paraformaldehyde (PFA) and incubated
with a FITC labelled monoclonal antibody against the active form
of caspase-3 (clone C92605, BD Pharmingen) diluted in 0.1%
saponin in PBS. After two washes with 0.1% saponin in PBS, cells
were resuspended in 1% PFA/PBS and analysed by FACS.
c Conformational change of Bax and Bak
Bak and Bax conformational change was analysed by FACS as
described [44]. Briefly, cells were fixed in 4% PFA, permeabi-
lized with 0.1% saponin in PBS/5% FCS and incubated with
polyclonal rabbit a-Bak (NT, Upstate Biotechnology), polyclon-
al rabbit a-Bax (NT, Upstate Biotechnology) or purified rabbit
IgG (control). After washing (26) with 0.1% saponin in PBS,
cells were incubated with a-rabbit-Alexa 647 antibody (Invitro-
gen) in 0.1% saponin/PBS/5% FCS, washed twice in 0.1%
saponin/PBS, resuspended in 1% PFA/PBS and analysed by
FACS.
d Analysis of calreticulin translocation
Calreticulin translocation to the outer plasma membrane was
analysed as described [49]. Briefly, cells were incubated with
rabbit anti-calreticulin pAb (Biomol) (30 min, 4uC), followed by
goat anti-rabbit-alexa647 secondary antibody (30 min, 4uC). After
washing twice PBS, cells were resuspended in a buffer containing
7-AAD and calreticulin was analysed in the 7-AAD2 cell
population by FACS.
Analysis of viral titers during Tc cell induced cell death
Anti-ECTV CD8+ Tc cells were generated and isolated as
described above, except that mice were immunized with 104
instead of 105 pfu HE-ECTV, such that none of the infected mice
contained any detectable ECTV in their spleens at the time of
harvest. Effector and MEF target cells (infected for the indicated
times before the assay) were co-incubated at 10:1 effector:target
cell ratio at 37uC, 7%CO2. After the indicated times of co-
incubation, thoroughly mixed cell suspensions were analyzed for
ECTV by plaque assay.
Supporting Information
Figure S1 Characterization of ECTV infection in MEF.wt cells.
A, MEF.wt cells were mocked treated or infected with Mo- or HE-
ECTV (moi 3:1) for 5 or 18 hours. ECTV antigen was detected by
using a polyclonal rabbit anti-ECTV serum and analysed by
FACS as described in materials and methods. Representative
histograms (left panel) and means+/2SEM of percent ECTV-
antigen-positive cells from 6 (5 h) or 2 (18 h) independent
experiments (right panel). B, MEF.wt cells were mocked treated
or infected with Mo- or HE-ECTV (moi 3:1) for 4 or 8 hours.
Total RNA was isolated, EVM025 cDNA (F1L) was amplified,
cloned and cDNA was analysed by agarose gel electrophoresis (left
panel). The bands were purified and sequenced. Amino acid
sequence alignments (right panel) are shown for the F1L BH3-like
domain from Mo- and HE-ECTV and Vaccinia virus (Obtained
from [34]). C, MEF.wt cells were mocked-treated or infected (5 h)
with Mo- or HE-ECTV and subsequently treated with stauros-
porin 500 nM. After 12 h PS translocation (annexin V-PE
staining) and membrane integrity (AAD staining) were analysed
by FACS. Data are given as mean+/2SEM of 3 independent
experiments. D, MEF.wt cells were mocked-treated, EV-Kb-
peptide-pulsed or infected with Mo- or HE-ECTV (moi 3:1) for
5 h. Cell were washed and incubated for 3 hours more and PS
translocation (annexin V-PE staining) and membrane integrity
(AAD staining), mitochondrial membrane potential (DiOC6(3))
and calreticulin expression on the cell membrane were analysed by
FACS as described in materials and methods.
Found at: doi:10.1371/journal.pone.0007512.s001 (1.57 MB TIF)
Figure S2 Characterization of ex vivo Tc cells from ECTV
infected mice. CD8+ cells (anti-ECTV ex vivo Tc cells) were
isolated by autoMACS from six-day HE-ECTV immune WT (B6),
gzmA2/2 or gzmA6B2/2 mice. A, Total RNA was isolated
and gzmA, gzmB, gzmC, and gzmK transcripts were analysed by
RT-PCR. EL4 served as negative and day 6 primary allogeneic Tc
cells as positive control. GADPH was analysed as housekeeping
gene. B, intracellular gzmA and gzmB protein expression detected
with anti-gzmA or anti-gzmB rabbit antiserum. Data shown are
representative histograms of anti-gzm fluorescence (top panel) and
means+/2SEM of percent gzm+ CD8+ cells (bottom panel) from
3 independent experiments.
Found at: doi:10.1371/journal.pone.0007512.s002 (2.07 MB TIF)
Author Contributions
Conceived and designed the experiments: JP EMG MMS ML MR AM.
Performed the experiments: JP EMG AK MR. Analyzed the data: JP
EMG AK ML MR AM. Contributed reagents/materials/analysis tools: JP
MMS ML MR AM. Wrote the paper: JP EMG MMS MR AM.
References
1. Wyllie AH (1980) Glucocorticoid-induced thymocyte apoptosis is associated with
endogenous endonuclease activation. Nature 284: 555–556.
2. Russell JH, Ley TJ (2002) Lymphocyte-mediated cytotoxicity. Annu Rev
Immunol 20: 323–370.
3. Rouvier E, Luciani MF, Golstein P (1993) Fas involvement in Ca(2+)-
independent T cell-mediated cytotoxicity. J Exp Med 177: 195–200.
4. Kagi D, Vignaux F, Ledermann B, Burki K, Depraetere V, et al. (1994) Fas and
perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science
265: 528–530.
5. Ashton-Rickardt PG (2005) The granule pathway of programmed cell death.
Crit Rev Immunol 25: 161–182.
6. Bossi G, Griffiths GM (2005) CTL secretory lysosomes: biogenesis and secretion
of a harmful organelle. Semin Immunol 17: 87–94.
7. Voskoboinik I, Smyth MJ, Trapani JA (2006) Perforin-mediated target-cell death
and immune homeostasis. Nat Rev Immunol 6: 940–952.
8. Simon MM, Kramer MD (1994) Granzyme A. Methods Enzymol 244: 68–79.
9. Lieberman J, Fan Z (2003) Nuclear war: the granzyme A-bomb. Curr Opin
Immunol 15: 553–559.
10. Trapani JA, Sutton VR (2003) Granzyme B: pro-apoptotic, antiviral and
antitumor functions. Curr Opin Immunol 15: 533–543.
11. Tschopp J (1994) Granzyme B. Methods Enzymology 244: 80–87.
12. Kagi D, Ledermann B, Burki K, Seiler P, Odermatt B, et al. (1994) Cytotoxicity
mediated by T cells and natural killer cells is greatly impaired in perforin-
deficient mice. Nature 369: 31–37.
13. Mullbacher A, Hla RT, Museteanu C, Simon MM (1999) Perforin is essential
for control of ectromelia virus but not related poxviruses in mice. J Virol 73:
1665–1667.
14. Mu¨llbacher A, Waring P, Hia RT, Tran T, Chin S, et al. (1999) Granzymes are
the essential downstream effector molecules for the control of primary virus
infections by cytolytic leukocytes. Proc Natl Acad Sci U S A 96: 13950–13955.
15. Pereira RA, Simon MM, Simmons A (2000) Granzyme A, a noncytolytic
component of CD8(+) cell granules, restricts the spread of herpes simplex virus in
Granzyme B and Mousepox
PLoS ONE | www.plosone.org 10 October 2009 | Volume 4 | Issue 10 | e7512
the peripheral nervous systems of experimentally infected mice. J Virol 74:
1029–1032.
16. Riera L, Gariglio M, Valente G, Mullbacher A, Museteanu C, et al. (2000)
Murine cytomegalovirus replication in salivary glands is controlled by both
perforin and granzymes during acute infection. Eur J Immunol 30: 1350–1355.
17. Wang Y, Lobigs M, Lee E, Mullbacher A (2004) Exocytosis and Fas mediated
cytolytic mechanisms exert protection from West Nile virus induced encephalitis
in mice. Immunol Cell Biol 82: 170–173.
18. Pardo J, Balkow S, Anel A, Simon MM (2002) Granzymes are essential for
natural killer cell-mediated and perf-facilitated tumor control. Eur J Immunol
32: 2881–2887.
19. Revell PA, Grossman WJ, Thomas DA, Cao X, Behl R, et al. (2005) Granzyme
B and the downstream granzymes C and/or F are important for cytotoxic
lymphocyte functions. J Immunol 174: 2124–2131.
20. Smyth MJ, Thia KY, Street SE, MacGregor D, Godfrey DI, et al. (2000)
Perforin-mediated cytotoxicity is critical for surveillance of spontaneous
lymphoma. J Exp Med 192: 755–760.
21. van den Broek ME, Kagi D, Ossendorp F, Toes R, Vamvakas S, et al. (1996)
Decreased tumor surveillance in perforin-deficient mice. J Exp Med 184:
1781–1790.
22. van den Broek MF, Kagi D, Zinkernagel RM, Hengartner H (1995) Perforin
dependence of natural killer cell-mediated tumor control in vivo. Eur J Immunol
25: 3514–3516.
23. Turk B, Stoka V (2007) Protease signalling in cell death: caspases versus cysteine
cathepsins. FEBS Lett 581: 2761–2767.
24. Chipuk JE, Green DR (2006) Dissecting p53-dependent apoptosis. Cell Death
Differ 13: 994–1002.
25. Adams JM, Cory S (2007) The Bcl-2 apoptotic switch in cancer development
and therapy. Oncogene 26: 1324–1337.
26. Benedict CA, Norris PS, Ware CF (2002) To kill or be killed: viral evasion of
apoptosis. Nat Immunol 3: 1013–1018.
27. Boya P, Roumier T, Andreau K, Gonzalez-Polo RA, Zamzami N, et al. (2003)
Mitochondrion-targeted apoptosis regulators of viral origin. Biochem Biophys
Res Commun 304: 575–581.
28. Callus BA, Vaux DL (2007) Caspase inhibitors: viral, cellular and chemical. Cell
Death Differ 14: 73–78.
29. Dobbelstein M, Shenk T (1996) Protection against apoptosis by the vaccinia
virus SPI-2 (B13R) gene product. J Virol 70: 6479–6485.
30. Macen JL, Garner RS, Musy PY, Brooks MA, Turner PC, et al. (1996)
Differential inhibition of the Fas- and granule-mediated cytolysis pathways by
the orthopoxvirus cytokine response modifier A/SPI-2 and SPI-1 protein. Proc
Natl Acad Sci U S A 93: 9108–9113.
31. Pickup DJ, Ink BS, Hu W, Ray CA, Joklik WK (1986) Hemorrhage in lesions
caused by cowpox virus is induced by a viral protein that is related to plasma
protein inhibitors of serine proteases. Proc Natl Acad Sci U S A 83: 7698–7702.
32. Fischer SF, Ludwig H, Holzapfel J, Kvansakul M, Chen L, et al. (2006) Modified
vaccinia virus Ankara protein F1L is a novel BH3-domain-binding protein and
acts together with the early viral protein E3L to block virus-associated apoptosis.
Cell Death Differ 13: 109–118.
33. Wasilenko ST, Banadyga L, Bond D, Barry M (2005) The vaccinia virus F1L
protein interacts with the proapoptotic protein Bak and inhibits Bak activation.
J Virol 79: 14031–14043.
34. Postigo A, Cross JR, Downward J, Way M (2006) Interaction of F1L with the
BH3 domain of Bak is responsible for inhibiting vaccinia-induced apoptosis. Cell
Death Differ.
35. Aoyagi M, Zhai D, Jin C, Aleshin AE, Stec B, et al. (2007) Vaccinia virus N1L
protein resembles a B cell lymphoma-2 (Bcl-2) family protein. Protein Sci 16:
118–124.
36. Fenner F (1949) Mouse-pox; infectious ectromelia of mice; a review. J Immunol
63: 341–373.
37. Mullbacher A, Wallich R, Moyer RW, Simon MM (1999) Poxvirus-encoded
serpins do not prevent cytolytic T cell-mediated recovery from primary
infections. J Immunol 162: 7315–7321.
38. Wallich R, Simon MM, Mullbacher A (2001) Virulence of mousepox virus is
independent of serpin-mediated control of cellular cytotoxicity. Viral Immunol
14: 71–81.
39. Turner SJ, Silke J, Kenshole B, Ruby J (2000) Characterization of the ectromelia
virus serpin, SPI-2. J Gen Virol 81: 2425–2430.
40. Brick DJ, Burke RD, Minkley AA, Upton C (2000) Ectromelia virus virulence
factor p28 acts upstream of caspase-3 in response to UV light-induced apoptosis.
J Gen Virol 81: 1087–1097.
41. Chen N, Danila MI, Feng Z, Buller RM, Wang C, et al. (2003) The genomic
sequence of ectromelia virus, the causative agent of mousepox. Virology 317:
165–186.
42. Pardo J, Balkow S, Anel A, Simon MM (2002) The differential contribution of
granzyme A and granzyme B in cytotoxic T lymphocyte-mediated apoptosis is
determined by the quality of target cells. Eur J Immunol 32: 1980–1985.
43. Pardo J, Bosque A, Brehm R, Wallich R, Naval J, et al. (2004) Apoptotic
pathways are selectively activated by granzyme A and/or granzyme B in CTL-
mediated target cell lysis. J Cell Biol 167: 457–468.
44. Pardo J, Wallich R, Martin P, Urban C, Rongvaux A, et al. (2008) Granzyme B-
induced cell death exerted by ex vivo CTL: discriminating requirements for cell
death and some of its signs. Cell Death Differ 15: 567–579.
45. Simon MM, Hausmann M, Tran T, Ebnet K, Tschopp J, et al. (1997) In vitro-
and ex vivo-derived cytolytic leukocytes from granzyme A6B double knockout
mice are defective in granule-mediated apoptosis but not lysis of target cells.
J Exp Med 186: 1781–1786.
46. Pham CT, MacIvor DM, Hug BA, Heusel JW, Ley TJ (1996) Long-range
disruption of gene expression by a selectable marker cassette. Proc Natl Acad
Sci U S A 93: 13090–13095.
47. Krzyzowska M, Schollenberger A, Skierski J, Niemialtowski M (2002) Apoptosis
during ectromelia orthopoxvirus infection is DEVDase dependent: in vitro and
in vivo studies. Microbes Infect 4: 599–611.
48. Gardai SJ, McPhillips KA, Frasch SC, Janssen WJ, Starefeldt A, et al. (2005)
Cell-surface calreticulin initiates clearance of viable or apoptotic cells through
trans-activation of LRP on the phagocyte. Cell 123: 321–334.
49. Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, et al. (2007)
Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med
13: 54–61.
50. Tewari M, Telford WG, Miller RA, Dixit VM (1995) CrmA, a poxvirus-
encoded serpin, inhibits cytotoxic T-lymphocyte-mediated apoptosis. J Biol
Chem 270: 22705–22708.
51. Blanden RV (1974) T cell response to viral and bacterial infection. Transplant
Rev 19: 56–88.
52. Mullbacher A, Blanden RV (2004) T-cell-mediated control of poxvirus infection
in mice. Prog Mol Subcell Biol 36: 39–55.
53. Mullbacher A, Ebnet K, Blanden RV, Hla RT, Stehle T, et al. (1996) Granzyme
A is critical for recovery of mice from infection with the natural cytopathic viral
pathogen, ectromelia. Proc Natl Acad Sci U S A 93: 5783–5787.
54. Regner M, Pavlinovic L, Koskinen A, Young N, Trapani JA, et al. (2009)
Cutting edge: Rapid and efficient in vivo cytotoxicity by cytotoxic T cells is
independent of granzymes A and B. J Immunol 183: 37–40.
55. Metkar SS, Menaa C, Pardo J, Wang B, Wallich R, et al. (2008) Human and
mouse granzyme A induce a proinflammatory cytokine response. Immunity 29:
720–733.
56. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, et al. (1997)
Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex
initiates an apoptotic protease cascade. Cell 91: 479–489.
57. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, et al. (2001)
Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction
and death. Science 292: 727–730.
58. Lakhani SA, Masud A, Kuida K, Porter GA, Jr., Booth CJ, et al. (2006)
Caspases 3 and 7: key mediators of mitochondrial events of apoptosis. Science
311: 847–851.
59. Tscharke DC, Karupiah G, Zhou J, Palmore T, Irvine KR, et al. (2005)
Identification of poxvirus CD8+ T cell determinants to enable rational design
and characterization of smallpox vaccines. J Exp Med 201: 95–104.
60. Martin P, Wallich R, Pardo J, Mullbacher A, Munder M, et al. (2005) Quiescent
and activated mouse granulocytes do not express granzyme A and B or perforin:
similarities or differences with human polymorphonuclear leukocytes? Blood
106: 2871–2878.
61. Pardo J, Wallich R, Ebnet K, Iden S, Zentgraf H, et al. (2007) Granzyme B is
expressed in mouse mast cells in vivo and in vitro and causes delayed cell death
independent of perforin. Cell Death Differ 14: 1768–1779.
Granzyme B and Mousepox
PLoS ONE | www.plosone.org 11 October 2009 | Volume 4 | Issue 10 | e7512
